Skip to main content
Erschienen in: World Journal of Surgery 8/2018

03.01.2018 | Original Scientific Report

Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes

verfasst von: Fabio Bagante, Gaya Spolverato, Matthew Weiss, Sorin Alexandrescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitano, Todd W. Bauer, Feng Shen, George A. Poultsides, Olivier Soubrane, Guillaume Martel, B. Groot Koerkamp, Alfredo Guglielmi, Endo Itaru, Andrea Ruzzenente, Timothy M. Pawlik

Erschienen in: World Journal of Surgery | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The consequences of lymphadenectomy (LND) on cirrhotic patients undergoing hepatectomy for intrahepatic cholangiocarcinoma (ICC) have not been investigated. We sought to analyze the impact of LND on morbidity among patients undergoing resection for ICC.

Methods

A total of 1005 patients who underwent hepatectomy for ICC at one of the 14 participating institutions between 1990 and 2015 were identified. A propensity score match analysis was performed to reduce confounding biases between cirrhosis and non-cirrhosis groups.

Results

Cirrhosis was diagnosed in 118 (11.7%) patients. Among non-cirrhotic patients, 63% underwent major liver resection versus only 20% among patients with cirrhosis (p < 0.001). LND was also less common among cirrhotic versus non-cirrhotic patients (19 vs. 50%, p < 0.001). The incidence of complications was 41 and 30% among patients who did not and did have cirrhosis, respectively (p = 0.022). The propensity-matched cohort included 150 patients. The incidence of complications was 71% among patients who underwent lymphadenectomy versus 23% among patients who did not undergo lymphadenectomy (OR 8.39) (p < 0.001). In the propensity-matched analysis, the median HLN was comparable among patients independent of cirrhosis status (median HLN: non-cirrhosis, 2.5 vs. cirrhosis, 2) (p = 0.95). While lymphadenectomy was associated with a higher risk of infections (non-cirrhosis, 0% vs. cirrhosis, 21%, p < 0.001) among patients with cirrhosis, infections were not associated with lymphadenectomy among non-cirrhotic patients (p = 0.19).

Conclusion

Lymphadenectomy was associated with an increased risk of complications among patients with cirrhosis undergoing surgery for ICC. The benefit of lymphadenectomy in cirrhotic patients should be considered in light of the higher risk of postoperative complications compared with non-cirrhotic patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Plentz RR, Malek NP (2015) Clinical presentation, risk factors and staging systems of cholangiocarcinoma. Best Pract Res Clin Gastroenterol 29:245–252CrossRefPubMed Plentz RR, Malek NP (2015) Clinical presentation, risk factors and staging systems of cholangiocarcinoma. Best Pract Res Clin Gastroenterol 29:245–252CrossRefPubMed
2.
Zurück zum Zitat Shin HR, Oh JK, Masuyer E et al (2010) Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 101:579–585CrossRefPubMed Shin HR, Oh JK, Masuyer E et al (2010) Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 101:579–585CrossRefPubMed
3.
Zurück zum Zitat Chan-On W, Kuwahara K, Kobayashi N et al (2009) Cholangiocarcinomas associated with long-term inflammation express the activation-induced cytidine deaminase and germinal center-associated nuclear protein involved in immunoglobulin V-region diversification. Int J Oncol 35:287–295PubMed Chan-On W, Kuwahara K, Kobayashi N et al (2009) Cholangiocarcinomas associated with long-term inflammation express the activation-induced cytidine deaminase and germinal center-associated nuclear protein involved in immunoglobulin V-region diversification. Int J Oncol 35:287–295PubMed
4.
Zurück zum Zitat Goral V (2017) Cholangiocarcinoma: new insights. Asian Pac J Cancer Prev 18:1469–1473PubMed Goral V (2017) Cholangiocarcinoma: new insights. Asian Pac J Cancer Prev 18:1469–1473PubMed
5.
Zurück zum Zitat Thinkhamrop K, Khuntikeo N, Phonjitt P et al (2015) Association between diabetes mellitus and fatty liver based on ultrasonography screening in the world’s highest cholangiocarcinoma incidence region, Northeast Thailand. Asian Pac J Cancer Prev 16:3931–3936CrossRefPubMed Thinkhamrop K, Khuntikeo N, Phonjitt P et al (2015) Association between diabetes mellitus and fatty liver based on ultrasonography screening in the world’s highest cholangiocarcinoma incidence region, Northeast Thailand. Asian Pac J Cancer Prev 16:3931–3936CrossRefPubMed
6.
Zurück zum Zitat Zhang H, Yang T, Wu M et al (2016) Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett 379:198–205CrossRefPubMed Zhang H, Yang T, Wu M et al (2016) Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett 379:198–205CrossRefPubMed
7.
Zurück zum Zitat Welzel TM, Graubard BI, El-Serag HB et al (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 5:1221–1228CrossRefPubMedPubMedCentral Welzel TM, Graubard BI, El-Serag HB et al (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 5:1221–1228CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Shaib YH, Davila JA, McGlynn K et al (2004) Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40:472–477CrossRefPubMed Shaib YH, Davila JA, McGlynn K et al (2004) Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40:472–477CrossRefPubMed
9.
Zurück zum Zitat Peng NF, Li LQ, Qin X et al (2011) Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus. Ann Surg Oncol 18:1258–1266CrossRefPubMed Peng NF, Li LQ, Qin X et al (2011) Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus. Ann Surg Oncol 18:1258–1266CrossRefPubMed
10.
Zurück zum Zitat Michelotti GA, Machado MV, Diehl AM (2013) NAFLD NASH and liver cancer. Nat Rev Gastroenterol Hepatol 10:656–665CrossRefPubMed Michelotti GA, Machado MV, Diehl AM (2013) NAFLD NASH and liver cancer. Nat Rev Gastroenterol Hepatol 10:656–665CrossRefPubMed
11.
Zurück zum Zitat Cauchy F, Fuks D, Zarzavadjian Le Bian A et al (2014) Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: the new scourges? World J Hepatol 6:306–314CrossRefPubMedPubMedCentral Cauchy F, Fuks D, Zarzavadjian Le Bian A et al (2014) Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: the new scourges? World J Hepatol 6:306–314CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Shaib YH, El-Serag HB, Davila JA et al (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128:620–626CrossRefPubMed Shaib YH, El-Serag HB, Davila JA et al (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128:620–626CrossRefPubMed
13.
Zurück zum Zitat Amin MB, American Joint Committee on Cancer (2017) AJCC cancer staging manual Chicago, American Joint Committee on Cancer, Springer Amin MB, American Joint Committee on Cancer (2017) AJCC cancer staging manual Chicago, American Joint Committee on Cancer, Springer
14.
Zurück zum Zitat Bagante F, Spolverato G, Weiss M et al. (2018) Assessment of the lymph node status in patients undergoing liver resection for intrahepatic cholangiocarcinoma: the new eighth edition AJCC staging system. J Gastrointest Surg 22(1):52–59CrossRefPubMed Bagante F, Spolverato G, Weiss M et al. (2018) Assessment of the lymph node status in patients undergoing liver resection for intrahepatic cholangiocarcinoma: the new eighth edition AJCC staging system. J Gastrointest Surg 22(1):52–59CrossRefPubMed
15.
Zurück zum Zitat Lee JH, Kim J, Cheong JH et al (2005) Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol 11:4623–4627CrossRefPubMedPubMedCentral Lee JH, Kim J, Cheong JH et al (2005) Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol 11:4623–4627CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Tachibana M, Kotoh T, Kinugasa S et al (2000) Esophageal cancer with cirrhosis of the liver: results of esophagectomy in 18 consecutive patients. Ann Surg Oncol 7:758–763CrossRefPubMed Tachibana M, Kotoh T, Kinugasa S et al (2000) Esophageal cancer with cirrhosis of the liver: results of esophagectomy in 18 consecutive patients. Ann Surg Oncol 7:758–763CrossRefPubMed
18.
Zurück zum Zitat Austin PC, Grootendorst P, Anderson GM (2007) A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 26:734–753CrossRefPubMed Austin PC, Grootendorst P, Anderson GM (2007) A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 26:734–753CrossRefPubMed
20.
Zurück zum Zitat Scaglione S, Kliethermes S, Cao G et al (2015) The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol 49:690–696CrossRefPubMed Scaglione S, Kliethermes S, Cao G et al (2015) The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol 49:690–696CrossRefPubMed
21.
Zurück zum Zitat Affo S, Yu LX, Schwabe RF (2017) The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annu Rev Pathol 12:153–186CrossRefPubMed Affo S, Yu LX, Schwabe RF (2017) The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annu Rev Pathol 12:153–186CrossRefPubMed
24.
Zurück zum Zitat Jeong S, Cheng Q, Huang L et al (2017) Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection. BMC Cancer 17:464CrossRefPubMedPubMedCentral Jeong S, Cheng Q, Huang L et al (2017) Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection. BMC Cancer 17:464CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Wang Y, Li J, Xia Y et al (2013) Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 31:1188–1195CrossRefPubMed Wang Y, Li J, Xia Y et al (2013) Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 31:1188–1195CrossRefPubMed
26.
Zurück zum Zitat Ali SM, Clark CJ, Mounajjed T et al (2015) Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience. HPB (Oxford) 17:244–250CrossRef Ali SM, Clark CJ, Mounajjed T et al (2015) Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience. HPB (Oxford) 17:244–250CrossRef
27.
Zurück zum Zitat Doussot A, Lim C, Gomez Gavara C et al (2016) Multicentre study of the impact of morbidity on long-term survival following hepatectomy for intrahepatic cholangiocarcinoma. Br J Surg 103:1887–1894CrossRefPubMed Doussot A, Lim C, Gomez Gavara C et al (2016) Multicentre study of the impact of morbidity on long-term survival following hepatectomy for intrahepatic cholangiocarcinoma. Br J Surg 103:1887–1894CrossRefPubMed
28.
Zurück zum Zitat Doussot A, Gonen M, Wiggers JK et al (2016) Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models. J Am Coll Surg 223:493–505CrossRefPubMedPubMedCentral Doussot A, Gonen M, Wiggers JK et al (2016) Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models. J Am Coll Surg 223:493–505CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Kim Y, Moris DP, Zhang XF et al. (2017) Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis. J Surg Oncol 116(6):643–650CrossRefPubMed Kim Y, Moris DP, Zhang XF et al. (2017) Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis. J Surg Oncol 116(6):643–650CrossRefPubMed
30.
Zurück zum Zitat Bagante F, Gani F, Spolverato G et al (2015) Intrahepatic cholangiocarcinoma: prognosis of patients who did not undergo lymphadenectomy. J Am Coll Surg 221:e1031–e1034CrossRef Bagante F, Gani F, Spolverato G et al (2015) Intrahepatic cholangiocarcinoma: prognosis of patients who did not undergo lymphadenectomy. J Am Coll Surg 221:e1031–e1034CrossRef
31.
Zurück zum Zitat Kim Y, Spolverato G, Amini N et al (2015) Surgical management of intrahepatic cholangiocarcinoma: defining an optimal prognostic lymph node stratification schema. Ann Surg Oncol 22:2772–2778CrossRefPubMed Kim Y, Spolverato G, Amini N et al (2015) Surgical management of intrahepatic cholangiocarcinoma: defining an optimal prognostic lymph node stratification schema. Ann Surg Oncol 22:2772–2778CrossRefPubMed
32.
Zurück zum Zitat Zhang XF, Chakedis J, Bagante F et al (accepted) Trends in utilization of lymphadenectomy in curative-intent surgery for intrahepatic cholangiocarcinoma. Brit J Surg Zhang XF, Chakedis J, Bagante F et al (accepted) Trends in utilization of lymphadenectomy in curative-intent surgery for intrahepatic cholangiocarcinoma. Brit J Surg
Metadaten
Titel
Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes
verfasst von
Fabio Bagante
Gaya Spolverato
Matthew Weiss
Sorin Alexandrescu
Hugo P. Marques
Luca Aldrighetti
Shishir K. Maithel
Carlo Pulitano
Todd W. Bauer
Feng Shen
George A. Poultsides
Olivier Soubrane
Guillaume Martel
B. Groot Koerkamp
Alfredo Guglielmi
Endo Itaru
Andrea Ruzzenente
Timothy M. Pawlik
Publikationsdatum
03.01.2018
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 8/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4453-1

Weitere Artikel der Ausgabe 8/2018

World Journal of Surgery 8/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.